GRHL2-TRAPPC9 Fusion FISH Probe
The GRHL2-TRAPPC9 Fusion FISH Probe is used to confirm a fusion of the GRHL2 and TRAPPC9 genes. The fusion of the GRHL2 and TRAPPC9 genes has been associated with Breast Invasive Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| GRHL2-TRAPPC9-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| GRHL2-TRAPPC9-20-RERE | 20 (40 μL) | 200 μL |
|
|
| GRHL2-TRAPPC9-20-REOR | 20 (40 μL) | 200 μL |
|
|
| GRHL2-TRAPPC9-20-REGO | 20 (40 μL) | 200 μL |
|
|
| GRHL2-TRAPPC9-20-REGR | 20 (40 μL) | 200 μL |
|
|
| GRHL2-TRAPPC9-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| GRHL2-TRAPPC9-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| GRHL2-TRAPPC9-20-OROR | 20 (40 μL) | 200 μL |
|
|
| GRHL2-TRAPPC9-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| GRHL2-TRAPPC9-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| GRHL2-TRAPPC9-20-GORE | 20 (40 μL) | 200 μL |
|
|
| GRHL2-TRAPPC9-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| GRHL2-TRAPPC9-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| GRHL2-TRAPPC9-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| GRHL2-TRAPPC9-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| GRHL2-TRAPPC9-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| GRHL2-TRAPPC9-20-GROR | 20 (40 μL) | 200 μL |
|
|
| GRHL2-TRAPPC9-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| GRHL2-TRAPPC9-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| GRHL2-TRAPPC9-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| GRHL2-TRAPPC9-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| GRHL2-TRAPPC9-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| GRHL2-TRAPPC9-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| GRHL2-TRAPPC9-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| GRHL2-TRAPPC9-20-AQAQ | 20 (40 μL) | 200 μL |
|
GRHL2 Gene Summary
The protein encoded by this gene is a transcription factor that can act as a homodimer or as a heterodimer with either GRHL1 or GRHL3. Defects in this gene are a cause of non-syndromic sensorineural deafness autosomal dominant type 28 (DFNA28).[provided by RefSeq, Mar 2009]
Gene Name: Grainyhead Like Transcription Factor 2
Chromosome: CHR8: 102504667 -102681952
Locus: 8q22.3
TRAPPC9 Gene Summary
This gene encodes a protein that likely plays a role in NF-kappa-B signaling. Mutations in this gene have been associated with autosomal-recessive cognitive disability. Alternatively spliced transcript variants have been described.[provided by RefSeq, Feb 2010]
Gene Name: Trafficking Protein Particle Complex 9
Chromosome: CHR8: 140742585 -141468678
Locus: 8q24.3
Gene Diseases
The GRHL2 TRAPPC9 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Breast Invasive Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|